Akari Therapeutics (AKTX) Non Operating Income (2014 - 2026)

Akari Therapeutics (AKTX) posted quarterly Non Operating Income of $444000.0 for Q1 2026, up 346.67% year-on-year from $99403.0 in Q1 2025, and up 122.36% on a QoQ basis from -$2.0 million in Q4 2025.

Akari Therapeutics (AKTX) Non Operating Income (2014 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has reported Non Operating Income for 13 consecutive years, with $444000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Non Operating Income rose 346.67% year-over-year to $444000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$402000.0 (down 132.19% YoY) and the FY2025 annual result came in at -$1.0 million, down 155.4% from the prior year.
  • Non Operating Income grew to $444000.0 in Q1 2026 per AKTX's latest filing, from -$2.0 million in the prior quarter.
  • Over the last five years, Non Operating Income for AKTX reached as high as $5.6 million in Q1 2023 and fell as low as -$2.0 million in Q4 2025.
  • A 5-year average of $586012.4 and a median of $279587.0 in 2022 frame the typical range for Non Operating Income.
  • The largest YoY upside for Non Operating Income was 1222.94% in 2025 against a maximum downside of 362.5% in 2025.
  • Year by year, Non Operating Income stood at $136174.0 in 2022, then surged by 599.11% to $952000.0 in 2023, then surged by 58.19% to $1.5 million in 2024, then plunged by 231.87% to -$2.0 million in 2025, then jumped by 122.36% to $444000.0 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $444000.0, -$2.0 million, and -$84000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 Akari Therapeutics 86.55 Mn 86.55 Mn - 444,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 444,000.00
Dec 31, 2025 -1.99 Mn
Sep 30, 2025 -84,000.00
Jun 30, 2025 1.22 Mn
Mar 31, 2025 -180,000.00
Dec 31, 2024 1.51 Mn
Sep 30, 2024 32,000.00
Jun 30, 2024 -109,000.00
Mar 31, 2024 423,000.00
Dec 31, 2023 952,000.00
Sep 30, 2023 -364,000.00
Jun 30, 2023 615,000.00
Mar 31, 2023 5.60 Mn
Jun 30, 2022 136,174.00
Jun 30, 2021 -16,334.00
Dec 31, 2020 85,659.00
Sep 30, 2020 1.16 Mn
Jun 30, 2020 -1.53 Mn
Mar 31, 2020 1.18 Mn
Dec 31, 2019 -3,710.00